Health Sector – UHC, National Health Policy, Family Planning, Health Insurance, etc.

Rare Diseases Care in India: Progress, Challenges, and Opportunities

Note4Students

From UPSC perspective, the following things are important :

Prelims level: Rare Diseases Definition

Mains level: Burden of Rare Diseases and Policy Interventions

In the news

What are Rare Diseases?

  • Global Perspective: Rare diseases are defined by the World Health Organization (WHO) as often debilitating lifelong diseases or disorders with a prevalence of 1 or less, per 1,000 population.
  • National Context: While India lacks a standardized definition, the Organisation of Rare Diseases – India suggests defining a disease as rare if it affects 1 in 5,000 people or less.

Rare Diseases: Key Facts and Figures

  • India issued its first National Policy on Rare Diseases in March 2021, offering comprehensive strategies for prevention and management.
  • Less than 5% of rare diseases have therapies available in India, yet they affect nearly 1/5th of the population.
  • The Union Government allocated ₹50 lakh per patient for rare diseases treatment, but only approximately 49% of the allocated funds have been utilized.
  • There are approximately 7,000-8,000 rare diseases in India, with new diseases continually being identified and reported.

 

National Policy on Rare Diseases, 2021: Highlights

  • Comprehensive Approach: This Policy offers a holistic framework encompassing prevention, management, and treatment strategies tailored to the unique needs of patients.
  • Financial Support: Recognizing the financial burden on patients, the policy aims to lower the exorbitant costs of treatment through targeted interventions and support mechanisms.
  • Research Focus: Emphasizing indigenous research, the policy lays the foundation for bolstering research initiatives in the field of rare diseases, fostering innovation and discovery.

Other Initiatives in India

  • National Hospital-Based Registry: A pivotal component of the policy, the establishment of a national registry of rare diseases promises to provide invaluable epidemiological data, informing targeted interventions and resource allocation.
  • Early Screening and Prevention: The creation of Nidan Kendras aims to enhance early detection and prevention efforts, crucial for improving patient outcomes and reducing disease burden.
  • Capacity Building: Strengthening secondary and tertiary health facilities at Centres of Excellence underscores the commitment to enhancing healthcare infrastructure and service delivery.

Challenges and Imperatives

  • Defining Rare Diseases: Despite significant progress, India lacks a standardized definition of rare diseases, necessitating clarity to guide policy and resource allocation effectively.
  • Funding Utilization: Concerns arise over the underutilization of allocated funds, highlighting the urgency to streamline resource allocation and enhance accountability mechanisms.
  • Patient Advocacy: Rare diseases patient advocacy groups play a pivotal role in advocating for timely access to treatment and sustainable funding support, urging policymakers and healthcare providers to prioritize patient-centric initiatives.

Way Forward

  • Sustainable Funding: Ensuring sustainable funding support for rare diseases treatment is paramount to safeguarding patient well-being and fostering equitable access to care.
  • National Registry Implementation: Accelerating the establishment of a hospital-based national registry is imperative to harness the power of data-driven decision-making and advance rare diseases research.
  • Multidisciplinary Care: The creation of comprehensive care centers, coupled with initiatives to support caregivers, represents a crucial step towards enhancing patient outcomes and fostering a supportive healthcare ecosystem.

Conclusion

  • As India commemorates World Rare Diseases Day, it stands at a pivotal juncture in its journey towards rare diseases care and advocacy.
  • By embracing a collaborative and patient-centric approach, India can surmount existing challenges, paving the way for a future where every individual affected by a rare disease receives the care and support they deserve.

Try this PYQ from CSP 2014:

Consider the following diseases

  1. Diphtheria
  2. Chickenpox
  3. Smallpox

Which of the above diseases has/have been eradicated in India?

(a) 1 and 2 only

(b) 3 only

(c) 1, 2 and 3

(d) None

 

Post your responses here.
0
Please leave a feedback on thisx

Get an IAS/IPS ranker as your 1: 1 personal mentor for UPSC 2024

Attend Now

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

JOIN THE COMMUNITY

Join us across Social Media platforms.

💥Mentorship New Batch Launch
💥Mentorship New Batch Launch